Sunday, March 01, 2026 1:58 AM ET
17 hours ago
A rapid-fire update on our 4th Industrial Revolution stocks and our other names17 hours ago
We're adding a stock to our Bullpen that is resistant to recessions, AI disruption1 day ago
Trump angering MAHA with glyphosate order gives Democrats an opening1 day ago
Novartis, Genentech file suit alleging illegal importation of prescription drug2 days ago
Healthy Returns: What's next for Novo Nordisk's next obesity drug CagriSema2 days ago
Novo Nordisk to slash Wegovy, Ozempic U.S. list prices by up to 50%4 days ago
Eli Lilly launches new form of Zepbound with a month of doses in one pen4 days ago
Novo Nordisk down 15% after weight loss drug fails to match Eli Lilly's in trial5 days ago
Healthy Returns: FDA chief Marty Makary on compounded GLP-1s, vaccines and China9 days ago
Kennedy defends Trump glyphosate order as MAHA erupts9 days ago
FDA chief calls for reforms as U.S. loses ground to China in early drug trials9 days ago
FDA agrees to review Moderna's mRNA flu vaccine application in a reversal10 days ago
FDA chief Marty Makary says more drugs should be available over the counter10 days ago
Danaher is tapping the M&A well yet again. But we might have had enough11 days ago
French prosecutors investigate Nestle, Danone over contaminated baby formula11 days ago
Novo Nordisk faces a defining year in the obesity drug market12 days ago
How largest health-care education company in U.S. is tackling growing jobs gap17 days ago
Novo CEO sees 15 million patient opportunity in Medicare obesity coverage17 days ago
Moderna says FDA refuses to review its application for experimental flu shot18 days ago
CVS tops quarterly estimates, reaffirms profit outlook as turnaround takes hold18 days ago
Florida law models what genetic disease testing could be18 days ago
FDA says Novo Nordisk's TV ad for obesity pill includes misleading claims18 days ago
Novo Nordisk sues Hims & Hers over copycat versions of Wegovy pill, injections19 days ago
Hims & Hers stops offering weight loss pill after threats of legal action19 days ago
Healthy Returns: Pfizer execs chart out obesity drug strategy21 days ago
White House launches direct-to-consumer drug site TrumpRx. Here's what to know23 days ago
Eli Lilly sees GLP-1 growth accelerating as Novo Nordisk braces for a decline23 days ago
Eli Lilly blows past quarterly estimates, posts strong outlook as GLP-1 sales soar24 days ago
Pfizer says obesity injection shows promise as monthly treatment in mid-stage trial25 days ago
Pfizer beats quarterly estimates despite Covid product decline, reaffirms outlook25 days ago
Merck tops quarterly estimates, posts modest outlook as generic competition looms25 days ago
Eli Lilly CEO: Medicare coverage of obesity drugs could support pill launch25 days ago
Eli Lilly plans $3.5 billion Pennsylvania manufacturing plant for obesity drugs29 days ago